Log in to save to my catalogue

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liv...

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2884675817

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease

About this item

Full title

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2023-11, Vol.29 (11), p.2939-2953

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the commonest cause of chronic liver disease worldwide and represents an unmet precision medicine challenge. We established a retrospective national cohort of 940 histologically defined patients (55.4% men, 44.6% women; median body mass index 31.3; 32% with type 2 diabetes) coverin...

Alternative Titles

Full title

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2884675817

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2884675817

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-023-02602-2

How to access this item